Abstract:Abstract: Objective The aim of this study is to investigate the expression and clinical significance of NEIL3(Nei like DNA glycosylase 3) in lung adenocarcinoma tissue, and to identify the effect of NEIL3 on the proliferation of lung adenocarcinoma cells and the underlying molecular mechanism. Methods Immunohistochemistry was used to detect the expression of NEIL3 in lung adenocarcinoma tissues, and the relationship between NEIL3 expression and the clinicopathological parameters, as well as the prognosis of patients were analyzed. After knockdown of NEIL3 expression in lung adenocarcinoma cell A549 through short hairpin RNA (shRNA), colony formation assay, 5-ethynyl-2′-deoxyuridine (EdU) assay and flow cytometry were employed to detect the alterations in cell proliferation. Changes of proliferation-related molecules Cyclin D1 and AKT/GSK3β/β-catenin signaling pathway were detected by using Western blot. Results NEIL3 expression was correlated with clinical stage, T stage and the overall survival time of lung adenocarcinoma patients (P<0.05). Down-regulation of NEIL3 induced G0/G1 phase arrest in A549 cells and inhibited cell proliferation in vitro (P<0.05). Mechanically, inhibition of NEIL3 promoted the proteasomal degradation of Cyclin D1. Additionally, down-regulation of NEIL3 suppressed the activation of the AKT/GSK3β/β-catenin signaling pathway(P<0.05). Conclusion NEIL3 may promote the proliferation of lung adenocarcinoma cells through the activation of AKT/GSK3β signaling pathway, which in turn inhibits the proteasomal degradation of Cyclin D1.